For participants from your baseline cohort this reduction was sustained at month 12 (34/618, 6%), falling to 2% at month 18 after the second MDA. (9.1K) GUID:?B28ADCD0-2F44-4B37-B11C-60EC5F1DA5E9 S4 Fig: Optical
ROCK inhibitors
For participants from your baseline cohort this reduction was sustained at month 12 (34/618, 6%), falling to 2% at month 18 after the second MDA. (9.1K) GUID:?B28ADCD0-2F44-4B37-B11C-60EC5F1DA5E9 S4 Fig: Optical